Sept. 20, 2021

Evaluation of the Department of Defense’s Mitigation of Foreign Suppliers in the Pharmaceutical Supply Chain (DODIG-2021-126)

Publicly Released: September 22, 2021

The objective of this evaluation was to determine whether the DoD mitigated the risks of disruptions to the pharmaceutical supply chain, which is heavily reliant on foreign suppliers, in accordance with DoD Instruction (DoDI) 4140.01.

Sept. 20, 2021

Project Announcement: Quality control review of the FY 2020 single audit of the Battelle Memorial Institute under Project No. D2022-DEV0SO-0002.000

We will be performing a quality control review of the FY 2020 single audit of the Battelle Memorial Institute under Project No. D2022-DEV0SO-0002.000.

Sept. 20, 2021

Project Announcement: Audit of Defense Critical Infrastructure Improvements at Military Installations in the Southeastern Continental United States to Mitigate the Effects of Extreme Weather Events (Project No. D2021-D000RG-0162.000)

We plan to begin the subject audit in September 2021. The objective of this audit is to determine to what extent military installations in the southeastern Continental United States have assessed the potential for extreme weather events and identified improvements needed to mitigate potential damage to Defense Critical Infrastructure.

Sept. 17, 2021

Project Announcement: Audit of Management and Oversight of DoD Vulnerability and Mitigation Programs for Protecting the DoD Information Network (Project No. D2021-D000CX0164.000)

We plan to begin the subject audit in September 2021. The objective of this audit is to determine the extent to which the DoD is managing and overseeing its vulnerability and mitigation programs for protecting the DoD Information Network from insider and external threats. We may revise the objective as the audit proceeds, and we will also consider suggestions from management for additional or revised objectives.

Sept. 15, 2021

Independent Auditor’s Report of Department of State Funds Transferred to DoD for Human Immunodeficiency Virus/ Acquired Immune Deficiency Syndrome Prevention (DODIG-2021-124)

Publicly Released: September 16, 2021

The objective of our review was to determine whether the DoD used the funds transferred from the DoS in accordance with the MOA between the DoD and the DoS to support efforts for the prevention, treatment, control of, and research on, HIV/AIDS.

Sept. 15, 2021

Audit of Military Services Special Assignment Airlift Mission Cargo Movement Requests (DODIG-2021-123)

Publicly Released: September 17, 2021

The objective of this audit was to determine whether Military Services requested timely airlift cargo movements through the U.S. Transportation Command (USTRANSCOM) in accordance with DoD guidance.

Sept. 14, 2021

Evaluation of U.S. Special Operations Command’s Supply Chain Risk Management for the Security, Acquisition, and Delivery of Specialized Equipment (DODIG-2021-125)

Publicly Released: September 16, 2021

We determined the extent to which the U.S. Special Operations Command (USSOCOM) developed and implemented supply chain risk management procedures in accordance with DoD policy to identify, assess, and mitigate risk during the acquisition and development of USSOCOM specialized equipment. Specialized equipment is equipment, material, supplies, and services required for special operations missions for which there is no Military Service common requirement.

Sept. 10, 2021

Project Announcement: Evaluation of the Screening of Displaced Persons from Afghanistan (Project No. D2021-DEVOPD-0161.000)

We plan to begin the subject evaluation in September 2021. This evaluation will determine the extent to which the DoD is managing and tracking displaced persons from Afghanistan through the biometrics enrollment, screening, and vetting process.

Sept. 8, 2021

Management Advisory Memorandum Regarding Internal Control Weaknesses Over TRICARE Payments for the Administration of COVID-19 Vaccines (Report No. DODIG-2021-122)

Publicly Released: September 10, 2021

The purpose of this memorandum is to inform DoD leadership of potential internal control weaknesses that we identified regarding TRICARE payments for the administration of coronavirus disease–2019 (COVID-19) vaccines administered to TRICARE beneficiaries from December 2020 through April 2021 and to document our recommendations to Defense Health Agency (DHA) officials.

Sept. 7, 2021

Quality Control Review of the BKD, LLP FY 2020 Single Audit of MRIGlobal and Related Entities (DODIG-2021-121)

Publicly Released: September 9, 2021

The objective of this quality control review was to determine whether BKD, LLP (BKD) performed the FY 2020 single audit of MRIGlobal and Related Entities (MRI) in accordance with generally accepted government auditing standards and Federal requirements for single audits.